Professor, Jordan Schnitzer Endowed Chair in Diabetes, Director Harold Schnitzer Diabetes Center, Division Head Endocrinology, Diabetes
OREGON HEALTH SCIENCES UNIVERSITY
Portland, OR, United States
Rodica Busui, MD, PhD is the Jordan Schnitzer Endowed Chair in Diabetes , Professor with Tenure and Division Head of Endocrinology, Diabetes and Clinical Nutrition, Director the Harold Schnitzer Diabetes Health Center at the Oregon Health&Science University. She is the 2023 ADA President for Medicine and Science, Professor Emeritus at the University of Michigan, an internationally recognized leader in the field of diabetes and diabetes complications. Her research interests involve chronic complications of diabetes, heart, kidney, neuropathy and diabetic foot, as well as the implementation of innovative technologies for diabetes management. She has been principal investigator and Steering Committee member in many landmark diabetes clinical trials funded by NIH, Foundations or Industry that have shaped the standards of care for people with diabetes worldwide including: DCCT/EDIC, PERL, ACCORD, BARI 2D, GRADE, T1D Exchange, REPLACE-BG, WISDM, MOBILE, DEVOTE, SELECT, SOUL. She also designed and leads several investigator-initiated studies to unveil disease modifying agents for diabetes complications, and on the use of diabetes technologies to improve patients’ outcomes and diabetes care delivery funded by NIDDK, NHLBI, and Industry. She is PI and the Chair of the NIDDK-funded Diabetes Foot Consortium and PIs of the Breakthrough T1D Center of Excellence to reverse cardio-renal complications in diabetes. She chaired the 2017 ADA Position Statement on Diabetic Neuropathy, the ADA Diabetes & Cardiovascular Disease Interest Group, and the ADA/ACC Heart Failure in Diabetes Consensus. As the ADA President for Medicine and Science she promoted creating the ADA Amputation Prevention Alliance.
Dr. Busui has published more than 370 peer-reviewed manuscripts, received awards for her research and advancement of diabetes care from the ADA, the European Association for the Study of Diabetes, the Fulbright Foundation, the Harvard Medical School, the Romanian Diabetes Society, the University of Michigan, and has been inducted in the Association of American Physicians.
Disclosure information not submitted.
ORF33 - Microvascular and Macrovascular Injury in Diabetes
Sunday, June 14, 2026
1:45 PM - 3:15 PM CT
MTP28 - Diabetic Nephropathy: What Is the Evidence in 2026 for Management of Diabetic Nephropathy?
Monday, June 15, 2026
1:45 PM - 2:25 PM CT